PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

被引：0
|
作者：
Perez-Larraya, J. Gallego [1 ]
Garcia-Moure, M. [2 ]
Gonzalez-Huarriz, M. [2 ]
Zalacain, M. [2 ]
Marrodan, L. [2 ]
Puigdelloses, M. [2 ]
Labiano, S.
de la Nava, D. [2 ]
Laspidea, V. [2 ,3 ]
Ausejo, I. [2 ]
Hervas, I. [2 ]
Esparragosa, I. [1 ]
Giraldez, M. [1 ]
Dominguez, P. [1 ]
Martinez-Simon, A. [1 ]
Idoate, M. [1 ]
Fueyo, J. [4 ]
Gomez-Manzano, C. [4 ]
Patino, A. [1 ]
Diez-Valle, R. [5 ]
Tejada, S. [5 ]
Alonso, M.
机构：
[1] Clin Univ Navarra, Pamplona, Spain
[2] Ctr Appl Med Res, Pamplona, Spain
[3] Univ Navarra, Pamplona, Spain
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Quiron Hosp, Madrid, Spain
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.404
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P17.14.B
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [21] PHASE 1B OPEN-LABEL RANDOMIZED STUDY OF THE ONCOLYTIC VIRUS DNX-2401 ADMINISTERED WITH OR WITHOUT INTERFERON GAMMA FOR RECURRENT GLIOBLASTOMA
    Tufaro, Frank
    Peterkin, Joanna
    Gammon, Karen
    Salvosa, Marita
    Mitchell, Erin
    Ewald, Brett
    Tonkin, Michele
    Rao, Pallavi
    Rowland, Kari Anne
    Chan, Winnie
    Forsythe, Sheri
    NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [22] RESULTS OF A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 WITH RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Garcia-Moure, Marc
    Gallego Perez-Larraya, Jaime
    Patino, Ana
    Gonzalez-Huarriz, Marisol
    Jones, Chris
    MacKay, Alan
    Van der Lugt, Jasper
    Hulleman, Esther
    de Andrea, Carlos
    Astigarraga, Itziar
    Garcia-Ariza, Miguel
    Lopez-Ibor, Blanca
    Villalba, Maria
    Lang, Frederick F.
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Dobbs, Jessica
    Diez-Valle, Ricardo
    Alonso, Marta M.
    Tejada, Sonia
    NEURO-ONCOLOGY, 2021, 23 : 47 - 47
  • [23] PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Cande
    Tufaro, Frank
    Sawaya, Raymond
    Weinberg, Jeffrey
    Prabhu, Sujit
    Fuller, Gregory
    Aldape, Kenneth
    Fueyo, Juan
    NEURO-ONCOLOGY, 2014, 16
  • [24] Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma
    She, Lei
    Su, Lin
    Shen, Liangfang
    Liu, Chao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] Phase I trial of TG02 plus dose-dense or metronomic temozolomide for recurrent anaplastic astrocytoma and glioblastoma in adults.
    Wu, Jing
    Yuan, Ying
    Cordova, Christine
    Aboud, Orwa
    Penas-Prado, Marta
    Theeler, Brett James
    Bryla, Christine
    Su, Yu-Ting
    Grajkowska, Ewa
    McCoy, Ann
    Boris, Lisa
    Siegel, Christine
    Antony, Ramya
    Garren, Nancy
    Lawhon, Tracy
    Armstrong, Terri
    Gilbert, Mark R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
    Gilbert, Mark R.
    Wang, Meihua
    Aldape, Kenneth D.
    Stupp, Roger
    Hegi, Monika E.
    Jaeckle, Kurt A.
    Armstrong, Terri S.
    Wefel, Jeffrey S.
    Won, Minhee
    Blumenthal, Deborah T.
    Mahajan, Anita
    Schultz, Christopher J.
    Erridge, Sara
    Baumert, Brigitta
    Hopkins, Kristen I.
    Tzuk-Shina, Tzahala
    Brown, Paul D.
    Chakravarti, Arnab
    Curran, Walter J., Jr.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4085 - +
  • [27] Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients
    Tejada, Sonia
    Alonso, Marta
    Patino, Ana
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Diez-Valle, Ricardo
    NEUROSURGERY, 2018, 83 (05) : 1050 - 1056
  • [28] Efficacy of bevacizumab combined with temozolomide dose-dense regimen on recurrent glioma
    Li, Jinli
    Huang, Weiwei
    Piao, Meina
    Liu, Zhengcao
    Ji, Shengjun
    Xue, Jing
    Zhu, Xin
    JOURNAL OF BUON, 2021, 26 (01): : 145 - 151
  • [29] Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients COMMENTS
    Miller, Jonathan P.
    Richardson, Robert Mark
    NEUROSURGERY, 2018, 83 (05) : 1066 - 1067
  • [30] NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
    Mark R. Gilbert
    Stephanie L. Pugh
    Ken Aldape
    A. Gregory Sorensen
    Tom Mikkelsen
    Marta Penas-Prado
    Felix Bokstein
    Young Kwok
    R. Jeffrey Lee
    Minesh Mehta
    Journal of Neuro-Oncology, 2017, 131 : 193 - 199
12345